4.3 Review

Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase

期刊

EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 15, 期 1, 页码 65-78

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/17512433.2022.2032659

关键词

Antipsychotic agents; administration and dosage; antipsychotic agents; adverse effects; antipsychotic agents; poisoning; antipsychotic agents; toxicity; mortality; drug effects; myocarditis; chemically induced; myocarditis; etiology; olanzapine; adverse effects; quetiapine; adverse effects; quetiapine; poisoning

向作者/读者索取更多资源

This review examines the association between antipsychotics (other than clozapine) and myocarditis through literature analysis and data from VigiBase. Quetiapine and olanzapine were found to have a significant statistical signal for myocarditis, with a high percentage of cases also involving co-prescription of clozapine. Further research is needed to investigate cases of myocarditis caused by antipsychotics during overdose or titration.
Introduction Pharmacovigilance studies have definitely established that clozapine can cause myocarditis. Two published reviews suggested that on rare occasions other antipsychotics may induce myocarditis. Areas covered This review explored myocarditis associated with antipsychotics other than clozapine by conducting a systematic search of the literature and critically analyzing the current data in VigiBase compared to the data on clozapine-associated myocarditis. VigiBase is the World Health Organization's global pharmacovigilance database that uses a statistical signal for associations with a logarithmic measure of disproportionality called the information component (IC). Expert opinion For quetiapine, VigiBase provided 106 reports of myocarditis and a significant statistical signal (IC = 1.8; IC025 = 1.5) which was confounded by 48% (51/106) with clozapine co-prescription. Combining the literature and VigiBase cases provided five probable myocarditis cases during quetiapine monotherapy (4 after overdose or rapid titration). For olanzapine, VigiBase provided 107 reports of myocarditis and a significant statistical signal (IC = 2.1; IC025 = 1.8) probably explained by 77% (82/107) using clozapine co-prescription. Combining the literature and VigiBase cases provided one probable myocarditis case during olanzapine monotherapy. Combining the literature and VigiBase provided another three probable cases during therapy with other antipsychotics during overdose or titration with a high dose.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据